life scienc tool diagnost increas target price
adjust estim recent share offer follow ep report may
announc commenc concurr offer billion share
common stock billion share seri mandatori convert prefer
stock notabl net proce issuanc gener corpor purpos
may includ potenti fund futur acquisit invest work capit
refinanc share repurchas dividend among use conjunct
close offer may rais adjust averag dilut share count
million million thereaft increas common stock
issuanc mcp issuanc ep move
respect
reiter outperform remain compon strategi nt
pandem certainli drive near-term headwind across dhr broader
busi continu invest meaning across innov initi util
danah busi system playbook drive increment oper effici
consid potenti new acquisit target recent complet
acquisit cytiva dissect ge biopharma deal post deal pro forma
leverag stand march recent capit rais offer increment
dri powder pro forma leverag enabl consid mid-siz bolt-on
deal enhanc competit posit across key area focu moreov
note histor complet success deal recessionari period
time econom disrupt exampl period complet
acquisit videojet million sciex billion
grown msd rang averag increment posit
bias dhr lt prospect particularli continu enhanc exposur
faster-grow end-market biopharma arena organ growth
 a/strateg divestitur evidenc recent complet acquisit
cytiva spin-off envista hold neutral initi note formerli
dentalco septemb rais tp
risk util macro condit miscu
valuat metric
number share
 close
legal entiti disclosur statu non-u analyst us disclosur credit suiss seek busi
compani cover research report result investor awar firm may conflict interest could
affect object report investor consid report singl factor make invest decis
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
price
lead manufactur system instrument
consum broad array purpos custom primari
dental environment health/appli scienc
blue sky scenario assum signific acceler
key end market global signific rebound dental trend better
expect implement db acquir compani market
share gain materi margin expans
grey sky scenario base signific weak
key end market prolong weak dental demand trend
deceler core growth acquisit integr headwind
 close
compani mention price
erin wilson wright certifi view express report accur reflect person view subject compani
secur part compens directli indirectli relat specif recommend view
express report
